1.How much have the perinatal outcomes of triplet pregnancies improved over the last two decades?
Kyu Sang KYEONG ; Jae Yoon SHIM ; Soo young OH ; Hye Sung WON ; Pil Ryang LEE ; Ahm KIM ; Sung Cheol YUN ; Pureun Narae KANG ; Suk Joo CHOI ; Cheong Rae ROH
Obstetrics & Gynecology Science 2019;62(4):224-232
OBJECTIVE: This study was conducted to demonstrate the temporal trends in perinatal outcomes of triplet pregnancies over the last two decades. METHODS: The medical records of patients with triplet pregnancies at two Korean tertiary-care hospitals from 1992 to 2012 were retrospectively reviewed in regard to maternal and neonatal outcomes. The study was divided into two periods for analysis: period I (1992–2001) and period II (2003–2012). RESULTS: Over a 21-year period, 65 women with triplet pregnancies and 185 neonates were analyzed. Period II, when compared with period I, was associated with improved maternal outcomes, characterized by a decreased incidence of preeclampsia (31.8% vs. 2.3%, P=0.002) and anemia (68.2% vs. 30.2%, P=0.003) during pregnancy. Regarding neonatal aspects, the composite morbidity of period II was significantly decreased compared with that of period I, as assessed with a generalized estimating equation for logistic regression (26.2% vs. 8.1%, P=0.03). Multivariable analysis revealed that the gestational age at delivery and the period were significantly associated with the composite neonatal morbidity (P<0.001 and 0.007, respectively). CONCLUSION: Improved neonatal morbidity was associated with a higher gestational age at delivery and with the more recent decade.
Anemia
;
Female
;
Gestational Age
;
Humans
;
Incidence
;
Infant, Newborn
;
Logistic Models
;
Medical Records
;
Pre-Eclampsia
;
Pregnancy
;
Pregnancy Outcome
;
Pregnancy, Triplet
;
Premature Birth
;
Retrospective Studies
;
Triplets
2.Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma
Kyoungdo MUN ; Jiwon HAN ; Pureun ROH ; Jonggeun PARK ; Gahee KIM ; Wonhee HUR ; Jeongwon JANG ; Jongyoung CHOI ; Seungkew YOON ; Youngkyoung YOU ; Hojoong CHOI ; Pilsoo SUNG
Journal of Liver Cancer 2023;23(2):341-349
Background:
/Aim: Cancer-associated fibroblasts (CAFs) play an immunosuppressive role in the tumor microenvironment (TME) of human cancers; however, their characteristics and role in hepatocellular carcinoma (HCC) remain to be elucidated.
Methods:
Nine tumor and surrounding liver tissue samples from patients with HCC who underwent surgery were used to isolate patient-derived CAFs. Cell morphology was observed using an optical microscope after culture, and cell phenotypes were evaluated using flow cytometry and immunoblotting. Cytokines secreted by CAFs into culture medium were quantified using a multiplex cytokine assay.
Results:
CAFs were abundant in the TME of HCC and were adjacent to immune cells. After culture, the CAFs and non-tumor fibroblasts exhibited spindle shapes. We observed a robust expression of alpha-smooth muscle actin and fibroblast activation protein in CAFs, whereas alpha-fetoprotein, epithelial cell adhesion molecule, platelet/endothelial cell adhesion molecule-1, and E-cadherin were not expressed in CAFs. Furthermore, CAFs showed high secretion of various cytokines, namely C-X-C motif chemokine ligand 12, interleukin (IL)-6, IL-8, and C-C motif chemokine ligand 2.
Conclusions
CAFs are abundant in the TME of HCC and play a crucial role in tumor progression. These fibroblasts secrete cytokines that promote tumor growth and metastasis.